Injection Bupernorphine with intrathecal injection Ropivacaine for intensity of pain relief in Cesarean section patients

Comparison of different doses of injection Bupernorphine with intrathecal injection Ropivacaine in Cesarean section patients. - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065962

Enrollment

150

Registered

2024-04-19

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 1- Obstetrics

Interventions

Intervention1: Intervention - Spinal anaesthesia with intrathecal injection Ropivacaine Comparator agent - Injection Bupernorphine: Spinal anaesthesia in LSCS patients will be used once on induction

30u injection Bupernorphine & 60u of injection Bupernorphine with plain injection Ropivacaine will be used intrathecally for Spinal anaesthesia

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing Elective Caesarean section ASA I/II Height between 145-160 cm Pregnant pregnancy weight between 45- 80 kg

Exclusion criteria

Exclusion criteria: Patients with coagulopathy; Patients with severe PIH, Pre-Eclampsia or Eclampsia; Patients with hepatic, cardiac, renal or neurological disease. Patients not willing for spinal anaesthesia

Design outcomes

Primary

Measure	Time frame
To study effect of intrathecal hyperbaric Ropivacaine 0.75% 2ml compared to intrathecal hyperbaric Ropivacaine 0.75% with two different dosage of Bupernorphine 30ug & 60ug for characteristics of sensory and motor blockade. And also the postoperative analgesia duration and analgesic requirements.Timepoint: 4 mths	—

Secondary

Measure	Time frame
Hemodynamic parameters Complications APGAR scoreTimepoint: 3-4 months	—

Countries

India

Contacts

Public ContactVeena Narayan Wetal

Assistant Professor

drveena2307@gmail.com7875447697

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026